1
|
Guo YQ, Wu GX, Peng C, Fan YQ, Li L, Liu F, Xiong L. New Bisabolane-Type Sesquiterpenoids from Curcuma longa and Their Anti-Atherosclerotic Activity. Molecules 2023; 28:2704. [PMID: 36985676 PMCID: PMC10058791 DOI: 10.3390/molecules28062704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 03/13/2023] [Accepted: 03/14/2023] [Indexed: 03/19/2023] Open
Abstract
To explore the sesquiterpenoids in Curcuma longa L. and their activity related to anti-atherosclerosis. The chemical compounds of the rhizomes of C. longa were separated and purified by multiple chromatography techniques. Their structures were established by a variety of spectroscopic experiments. The absolute configurations were determined by comparing experimental and calculated NMR chemical shifts and electronic circular dichroism (ECD) spectra. Their anti-inflammatory effects and inhibitory activity against macrophage-derived foam cell formation were evaluated by lipopolysaccharide (LPS) and oxidized low-density lipoprotein (ox-LDL)-injured RAW264.7 macrophages, respectively. This study resulted in the isolation of 10 bisabolane-type sesquiterpenoids (1-10) from C. longa, including two pairs of new epimers (curbisabolanones A-D, 1-4). Compound 4 significantly inhibited LPS-induced nitric oxide (NO), interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) production in RAW264.7 cells. Furthermore, compound 4 showed inhibitory activity against macrophage-derived foam cell formation, which was represented by markedly reducing ox-LDL-induced intracellular lipid accumulation as well as total cholesterol (TC), free cholesterol (FC), and cholesterol ester (CE) contents in RAW264.7 cells. These findings suggest that bisabolane-type sesquiterpenoids, one of the main types of components in C. longa, have the potential to alleviate the atherosclerosis process by preventing inflammation and inhibiting macrophage foaming.
Collapse
Affiliation(s)
- Yu-Qin Guo
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Guang-Xu Wu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Cheng Peng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Yun-Qiu Fan
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Lei Li
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Fei Liu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Liang Xiong
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
- Institute of Innovative Medicine Ingredients of Southwest Specialty Medicinal Materials, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| |
Collapse
|
2
|
Caprioglio D, Salamone S, Pollastro F, Minassi A. Biomimetic Approaches to the Synthesis of Natural Disesquiterpenoids: An Update. PLANTS (BASEL, SWITZERLAND) 2021; 10:plants10040677. [PMID: 33916090 PMCID: PMC8065479 DOI: 10.3390/plants10040677] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/20/2021] [Revised: 03/30/2021] [Accepted: 03/30/2021] [Indexed: 06/12/2023]
Abstract
Natural disesquiterpenoids represent a small group of secondary metabolites characterized by complex molecular scaffolds and interesting pharmacological profiles. In the last decade, more than 400 new disesquiterpenoids have been discovered and fully characterized, pointing out once more the "magic touch" of nature in the design of new compounds. The perfect blend of complex and unique architectures and biological activity has made sesquiterpene dimers an attractive and challenging synthetic target, inspiring organic chemists to find new and biomimetic approaches to replicate the efficiency and the selectivity of natural processes under laboratory conditions. In this work, we present a review covering the literature from 2010 to 2020 reporting all the efforts made in the total synthesis of complex natural disesquiterpenoids.
Collapse
Affiliation(s)
- Diego Caprioglio
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, L.go Donegani 2/3, 28100 Novara, Italy; (D.C.); (S.S.); (F.P.)
| | - Stefano Salamone
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, L.go Donegani 2/3, 28100 Novara, Italy; (D.C.); (S.S.); (F.P.)
| | - Federica Pollastro
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, L.go Donegani 2/3, 28100 Novara, Italy; (D.C.); (S.S.); (F.P.)
- PlantaChem srls, via Canobio 4/6, 28100 Novara, Italy
| | - Alberto Minassi
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, L.go Donegani 2/3, 28100 Novara, Italy; (D.C.); (S.S.); (F.P.)
- PlantaChem srls, via Canobio 4/6, 28100 Novara, Italy
| |
Collapse
|
3
|
Daressy F, Malard F, Seguy L, Guérineau V, Apel C, Dumontet V, Robert A, Groo AC, Litaudon M, Bignon J, Desrat S, Malzert-Fréon A, Wiels J, Lescop E, Roussi F. Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL-1. ChemMedChem 2021; 16:1788-1797. [PMID: 33665938 DOI: 10.1002/cmdc.202100011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 02/15/2021] [Indexed: 01/27/2023]
Abstract
Drimane sesquiterpenoid dialdehydes are natural compounds with antiproliferative properties. Nevertheless, their mode of action has not yet been discovered. Herein, we demonstrate that various drimanes are potent inhibitors of MCL-1 and BCL-xL, two proteins of the BCL-2 family that are overexpressed in various cancers, including lymphoid malignancies. Subtle changes in their structure significantly modified their activity on the target proteins. The two most active compounds are MCL-1 selective and bind in the BH3 binding groove of the protein. Complementary studies by NMR spectroscopy and mass spectrometry analyses, but also synthesis, showed that they covalently inhibit MCL-1 though the formation of a pyrrole adduct. In addition, cytotoxic assays revealed that these two compounds show a cytotoxic selectivity for BL2, a MCL-1/BCL-xL-dependent cell line and induce apoptosis.
Collapse
Affiliation(s)
- Florian Daressy
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France.,Institut Gustave Roussy, CNRS UMR8126, Université Paris-Saclay, 114 rue Edouard-Vaillant, 94805, Villejuif Cedex, France.,UMR9018 CNRS, Institut Gustave Roussy, Université Paris-Saclay, 114 rue Edouard-Vaillant, 94805, Villejuif, France
| | - Florian Malard
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Line Seguy
- Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), UNICAEN, Normandie Université, Boulevard Becquerel, 14032, Caen Cedex, France
| | - Vincent Guérineau
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Cécile Apel
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Vincent Dumontet
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Aude Robert
- Institut Gustave Roussy, CNRS UMR8126, Université Paris-Saclay, 114 rue Edouard-Vaillant, 94805, Villejuif Cedex, France.,Université Paris-Saclay, Inserm, Institut Gustave Roussy, UMR1279, 114 rue Edouard-Vaillant, 94805, Villejuif, France
| | - Anne-Claire Groo
- Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), UNICAEN, Normandie Université, Boulevard Becquerel, 14032, Caen Cedex, France
| | - Marc Litaudon
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Jérôme Bignon
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Sandy Desrat
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Aurélie Malzert-Fréon
- Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), UNICAEN, Normandie Université, Boulevard Becquerel, 14032, Caen Cedex, France
| | - Joëlle Wiels
- Institut Gustave Roussy, CNRS UMR8126, Université Paris-Saclay, 114 rue Edouard-Vaillant, 94805, Villejuif Cedex, France.,UMR9018 CNRS, Institut Gustave Roussy, Université Paris-Saclay, 114 rue Edouard-Vaillant, 94805, Villejuif, France
| | - Ewen Lescop
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| | - Fanny Roussi
- Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, Avenue de la terrasse, 91198, Gif-sur-Yvette Cedex, France
| |
Collapse
|
4
|
Gapil Tiamas S, Daressy F, Abou Samra A, Bignon J, Steinmetz V, Litaudon M, Fourneau C, Hoong Leong K, Ariffin A, Awang K, Desrat S, Roussi F. Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2. Bioorg Med Chem Lett 2020; 30:127003. [PMID: 32035700 DOI: 10.1016/j.bmcl.2020.127003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 01/30/2020] [Accepted: 02/01/2020] [Indexed: 12/14/2022]
Abstract
A library of 26 novel carboxamides deriving from natural fislatifolic acid has been prepared. The synthetic strategy involved a bio-inspired Diels-Alder cycloaddition, followed by functionalisations of the carbonyl moiety. All the compounds were evaluated on Bcl-xL, Mcl-1 and Bcl-2 proteins. In this series of cyclohexenyl chalcone analogues, six compounds behaved as dual Bcl-xL/Mcl-1 inhibitors in micromolar range and one exhibited sub-micromolar affinities toward Mcl-1 and Bcl-2. The most potent compounds evaluated on A549 and MCF7 cancer cell lines showed moderate cytotoxicities.
Collapse
Affiliation(s)
- Shelly Gapil Tiamas
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France; Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Florian Daressy
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France; Université Paris-Saclay, UMR CNRS 8126, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94805 Villejuif Cedex, France
| | - Alma Abou Samra
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France
| | - Jérome Bignon
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France
| | - Vincent Steinmetz
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France
| | - Marc Litaudon
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France
| | - Christophe Fourneau
- Université Paris-Saclay, BioCIS, Faculté de Pharmacie de Châtenay-Malabry, 5 rue Jean-Baptiste Clément, 92296 Châtenay-Malabry, France
| | - Kok Hoong Leong
- Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Azhar Ariffin
- Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Khalijah Awang
- Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Sandy Desrat
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France.
| | - Fanny Roussi
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France.
| |
Collapse
|
5
|
Abstract
This review highlights the progress on the isolation, bioactivity, biogenesis and total synthesis of dimeric sesquiterpenoids since 2010.
Collapse
Affiliation(s)
- Lie-Feng Ma
- College of Pharmaceutical Science
- Zhejiang University of Technology
- Hangzhou
- P. R. China
| | - Yi-Li Chen
- College of Pharmaceutical Science
- Zhejiang University of Technology
- Hangzhou
- P. R. China
| | - Wei-Guang Shan
- College of Pharmaceutical Science
- Zhejiang University of Technology
- Hangzhou
- P. R. China
| | - Zha-Jun Zhan
- College of Pharmaceutical Science
- Zhejiang University of Technology
- Hangzhou
- P. R. China
| |
Collapse
|
6
|
Abstract
Although boronic acids are recognized primarily for their utility as reagents in transition metal-catalyzed transformations, other applications are emerging, including their use as reaction catalysts.
Collapse
Affiliation(s)
- Dennis G. Hall
- Department of Chemistry
- University of Alberta
- Edmonton
- Canada
| |
Collapse
|
7
|
Remeur C, Desrat S, Gandon V, Roussi F. Selectivity in the Intermolecular Diels-Alder Reaction of Conjugated Trienes: Experimental and Theoretical Approaches. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800472] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Camille Remeur
- Institut de Chimie des Substances Naturelles; CNRS-ICSN UPR 2301; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Sandy Desrat
- Institut de Chimie des Substances Naturelles; CNRS-ICSN UPR 2301; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Vincent Gandon
- Institut de Chimie des Substances Naturelles; CNRS-ICSN UPR 2301; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
- ICMMO; CNRS UMR 8182; Univ Paris-Sud; Université Paris-Saclay; Bât. 420 91405 Orsay cedex France
| | - Fanny Roussi
- Institut de Chimie des Substances Naturelles; CNRS-ICSN UPR 2301; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| |
Collapse
|
8
|
Tiamas SG, Audet F, Samra AA, Bignon J, Litaudon M, Fourneau C, Ariffin A, Awang K, Desrat S, Roussi F. Asymmetric Total Synthesis and Biological Evaluation of Proapoptotic Natural Myrcene-Derived Cyclohexenyl Chalcones. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800262] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Shelly Gapil Tiamas
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
- Department of Chemistry; Faculty of Science; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Florian Audet
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| | - Alma Abou Samra
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| | - Jérome Bignon
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| | - Marc Litaudon
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| | - Christophe Fourneau
- BioCIS; Faculté de Pharmacie de Châtenay-Malabry; Université Paris-Saclay; 5 rue Jean-Baptiste Clément 92296 Châtenay-Malabry France
| | - Azhar Ariffin
- Department of Chemistry; Faculty of Science; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Khalijah Awang
- Department of Chemistry; Faculty of Science; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Sandy Desrat
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| | - Fanny Roussi
- Institut de Chimie des Substances Naturelles (ICSN) UPR2301; CNRS; Université Paris-Saclay; Avenue de la Terrasse 91198 Gif-sur-Yvette CEDEX France
| |
Collapse
|
9
|
Abstract
Inflammation is recently recognized as one of the hallmarks of human cancer. Chronic inflammatory response plays a critical role in cancer development, progression, metastasis, and resistance to chemotherapy. Conversely, the oncogenic aberrations also generate an inflammatory microenvironment, enabling the development and progression of cancer. The molecular mechanisms of action that are responsible for inflammatory cancer and cancer-associated inflammation are not fully understood due to the complex crosstalk between oncogenic and pro-inflammatory genes. However, molecular mediators that regulate both inflammation and cancer, such as NF-κB and STAT have been considered as promising targets for preventing and treating these diseases. Recent works have further demonstrated an important role of oncogenes (e.g., NFAT1, MDM2) and tumor suppressor genes (e.g., p53) in cancer-related inflammation. Natural products that target these molecular mediators have shown anticancer and anti-inflammatory activities in preclinical and clinical studies. Sesquiterpenoids (STs), a class of novel plant-derived secondary metabolites have attracted great interest in recent years because of their diversity in chemical structures and pharmacological activities. At present, we and other investigators have found that dimeric sesquiterpenoids (DSTs) may exert enhanced activity and binding affinity to molecular targets due to the increased number of alkylating centers and improved conformational flexibility and lipophilicity. Here, we focus our discussion on the activities and mechanisms of action of STs and DSTs in treating inflammation and cancer as well as their structure-activity relationships.
Collapse
|
10
|
Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A. Eur J Med Chem 2018; 148:26-38. [DOI: 10.1016/j.ejmech.2018.01.100] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2017] [Revised: 01/29/2018] [Accepted: 01/31/2018] [Indexed: 11/23/2022]
|
11
|
Takahashi K, Matsui M, Kuse M, Takikawa H. First synthesis of (S)-(+)-hymenoic acid, a DNA polymerase λ inhibitor isolated from Hymenochaetaceae sp. Biosci Biotechnol Biochem 2018; 82:42-45. [DOI: 10.1080/09168451.2017.1406302] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Abstract
Hymenoic acid, isolated from cultures of the fungus, Hymenochaetaceae sp., is a specific inhibitor of DNA polymerase λ. The first synthesis of (S)-(+)-hymenoic acid was achieved by starting from trans-1,4-cyclohexanedimethanol and methyl (R)-(−)-3-hydroxyisobutyrate, and Julia–Kocienski olefination was employed as the key step.
Collapse
Affiliation(s)
- Kensuke Takahashi
- Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University, Kobe, Japan
| | - Miki Matsui
- Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University, Kobe, Japan
| | - Masaki Kuse
- Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University, Kobe, Japan
| | - Hirosato Takikawa
- Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University, Kobe, Japan
| |
Collapse
|
12
|
Pandey MK, Prasad S, Tyagi AK, Deb L, Huang J, Karelia DN, Amin SG, Aggarwal BB. Targeting Cell Survival Proteins for Cancer Cell Death. Pharmaceuticals (Basel) 2016; 9:11. [PMID: 26927133 PMCID: PMC4812375 DOI: 10.3390/ph9010011; 10.3390/biomedicines5020030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Escaping from cell death is one of the adaptations that enable cancer cells to stave off anticancer therapies. The key players in avoiding apoptosis are collectively known as survival proteins. Survival proteins comprise the Bcl-2, inhibitor of apoptosis (IAP), and heat shock protein (HSP) families. The aberrant expression of these proteins is associated with a range of biological activities that promote cancer cell survival, proliferation, and resistance to therapy. Several therapeutic strategies that target survival proteins are based on mimicking BH3 domains or the IAP-binding motif or competing with ATP for the Hsp90 ATP-binding pocket. Alternative strategies, including use of nutraceuticals, transcriptional repression, and antisense oligonucleotides, provide options to target survival proteins. This review focuses on the role of survival proteins in chemoresistance and current therapeutic strategies in preclinical or clinical trials that target survival protein signaling pathways. Recent approaches to target survival proteins-including nutraceuticals, small-molecule inhibitors, peptides, and Bcl-2-specific mimetic are explored. Therapeutic inventions targeting survival proteins are promising strategies to inhibit cancer cell survival and chemoresistance. However, complete eradication of resistance is a distant dream. For a successful clinical outcome, pretreatment with novel survival protein inhibitors alone or in combination with conventional therapies holds great promise.
Collapse
Affiliation(s)
- Manoj K Pandey
- Department of Pharmacology, College of Medicine, Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA.
| | - Sahdeo Prasad
- Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| | - Amit Kumar Tyagi
- Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| | - Lokesh Deb
- Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| | - Jiamin Huang
- Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| | - Deepkamal N Karelia
- Department of Pharmacology, College of Medicine, Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA.
| | - Shantu G Amin
- Department of Pharmacology, College of Medicine, Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA.
| | - Bharat B Aggarwal
- Department of Experimental Therapeutics, Cytokine Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| |
Collapse
|
13
|
Targeting Cell Survival Proteins for Cancer Cell Death. Pharmaceuticals (Basel) 2016; 9:ph9010011. [PMID: 26927133 PMCID: PMC4812375 DOI: 10.3390/ph9010011] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2015] [Revised: 02/08/2016] [Accepted: 02/16/2016] [Indexed: 12/18/2022] Open
Abstract
Escaping from cell death is one of the adaptations that enable cancer cells to stave off anticancer therapies. The key players in avoiding apoptosis are collectively known as survival proteins. Survival proteins comprise the Bcl-2, inhibitor of apoptosis (IAP), and heat shock protein (HSP) families. The aberrant expression of these proteins is associated with a range of biological activities that promote cancer cell survival, proliferation, and resistance to therapy. Several therapeutic strategies that target survival proteins are based on mimicking BH3 domains or the IAP-binding motif or competing with ATP for the Hsp90 ATP-binding pocket. Alternative strategies, including use of nutraceuticals, transcriptional repression, and antisense oligonucleotides, provide options to target survival proteins. This review focuses on the role of survival proteins in chemoresistance and current therapeutic strategies in preclinical or clinical trials that target survival protein signaling pathways. Recent approaches to target survival proteins-including nutraceuticals, small-molecule inhibitors, peptides, and Bcl-2-specific mimetic are explored. Therapeutic inventions targeting survival proteins are promising strategies to inhibit cancer cell survival and chemoresistance. However, complete eradication of resistance is a distant dream. For a successful clinical outcome, pretreatment with novel survival protein inhibitors alone or in combination with conventional therapies holds great promise.
Collapse
|
14
|
Desrat S, Remeur C, Roussi F. Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins. Org Biomol Chem 2015; 13:5520-31. [DOI: 10.1039/c5ob00354g] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The synthesis, on a large scale, with very good yield and er via an efficient strategy, of a chiral 4-substituted 2-cyclohexenone intermediate, was a milestone in the synthesis of seven analogues of meiogynin A, a natural sesquiterpenoid dimer.
Collapse
Affiliation(s)
- Sandy Desrat
- Centre de Recherche de Gif
- Institut de Chimie des Substances Naturelles (ICSN)
- CNRS UPR 2301
- Université Paris Sud Labex CEBA
- 91 198 Gif-sur-Yvette Cedex
| | - Camille Remeur
- Centre de Recherche de Gif
- Institut de Chimie des Substances Naturelles (ICSN)
- CNRS UPR 2301
- Université Paris Sud Labex CEBA
- 91 198 Gif-sur-Yvette Cedex
| | - Fanny Roussi
- Centre de Recherche de Gif
- Institut de Chimie des Substances Naturelles (ICSN)
- CNRS UPR 2301
- Université Paris Sud Labex CEBA
- 91 198 Gif-sur-Yvette Cedex
| |
Collapse
|
15
|
Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1. Bioorg Med Chem Lett 2014; 24:5086-8. [DOI: 10.1016/j.bmcl.2014.09.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2014] [Revised: 08/28/2014] [Accepted: 09/01/2014] [Indexed: 01/28/2023]
|
16
|
Desrat S, Remeur C, Gény C, Rivière G, Colas C, Dumontet V, Birlirakis N, Iorga BI, Roussi F. From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins. Chem Commun (Camb) 2014; 50:8593-6. [DOI: 10.1039/c4cc01830c] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
17
|
Immekus F, Barandun LJ, Betz M, Debaene F, Petiot S, Sanglier-Cianferani S, Reuter K, Diederich F, Klebe G. Launching spiking ligands into a protein-protein interface: a promising strategy to destabilize and break interface formation in a tRNA modifying enzyme. ACS Chem Biol 2013; 8:1163-78. [PMID: 23534552 DOI: 10.1021/cb400020b] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Apart from competitive active-site inhibition of protein function, perturbance of protein-protein interactions by small molecules in oligodomain enzymes opens new perspectives for innovative therapeutics. tRNA-guanine transglycosylase (TGT), a potential target to treat shigellosis, is active only as the homodimer. Consequently, disruption of the dimer interface by small molecules provides a novel inhibition mode. A special feature of this enzyme is the short distance between active site and rim of the dimer interface. This suggests design of expanded active-site inhibitors decorated with rigid, needle-type substituents to spike into potential hot spots of the interaction interface. Ligands with attached ethinyl-type substituents have been synthesized and characterized by Kd measurements, crystallography, noncovalent mass spectrometry, and computer simulations. In contrast to previously determined crystal structures with nonextended active-site inhibitors, a well-defined loop-helix motif, involved in several contacts across the dimer interface, falls apart and suggests enhanced flexibility once the spiking ligands are bound. Mass spectrometry indicates significant destabilization but not full disruption of the complexed TGT homodimer in solution. As directed interactions of the loop-helix motif obviously do not determine dimer stability, a structurally conserved hydrophobic patch composed of several aromatic amino acids is suggested as interaction hot spot. The residues of this patch reside on a structurally highly conserved helix-turn-helix motif, which remains unaffected by the bound spiking ligands. Nevertheless, it is shielded from solvent access by the loop-helix motif that becomes perturbed upon binding of the spiking ligands, which serves as a possible explanation for reduced interface stability.
Collapse
Affiliation(s)
- Florian Immekus
- Institut für Pharmazeutische
Chemie, Philipps-Universität Marburg, Marbacher Weg 6, 35032 Marburg, Germany
| | - Luzi Jakob Barandun
- Laboratorium für Organische
Chemie, ETH Zurich Hönggerberg, HCI, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland
| | - Michael Betz
- Institut für Pharmazeutische
Chemie, Philipps-Universität Marburg, Marbacher Weg 6, 35032 Marburg, Germany
| | - François Debaene
- Laboratoire de Spectrométrie de Masse Bio-Organique de Strasbourg, 25, rue Becquerel,
67087 Strasbourg Cedex 2, France
| | - Stéphanie Petiot
- Laboratoire de Spectrométrie de Masse Bio-Organique de Strasbourg, 25, rue Becquerel,
67087 Strasbourg Cedex 2, France
| | - Sarah Sanglier-Cianferani
- Laboratoire de Spectrométrie de Masse Bio-Organique de Strasbourg, 25, rue Becquerel,
67087 Strasbourg Cedex 2, France
| | - Klaus Reuter
- Institut für Pharmazeutische
Chemie, Philipps-Universität Marburg, Marbacher Weg 6, 35032 Marburg, Germany
| | - François Diederich
- Laboratorium für Organische
Chemie, ETH Zurich Hönggerberg, HCI, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland
| | - Gerhard Klebe
- Institut für Pharmazeutische
Chemie, Philipps-Universität Marburg, Marbacher Weg 6, 35032 Marburg, Germany
| |
Collapse
|
18
|
Dardenne J, Desrat S, Guéritte F, Roussi F. Asymmetric Synthesis of Two Analogues of Meiogynin A. European J Org Chem 2013. [DOI: 10.1002/ejoc.201201628] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
19
|
Kim YB, Del Valle JR. Synthesis of a diversifiable cis-dehydrodecalin scaffold based on meiogynin A. Tetrahedron Lett 2011. [DOI: 10.1016/j.tetlet.2011.09.061] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
20
|
|